đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This is a study to evaluate the safety and immunogenicity of V212 vaccine i...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-21
Trial ID
NCT01527383
LA rVSVÎG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Status
Completed
Location
Centre de Recherches MĂŠdicales de LambarĂŠnĂŠ
Start Date
2021-04-09
Trial ID
NCT05130398
The study is being conducted to demonstrate that V221 may be administered c...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00109343
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
Hepatitis A vaccine will be given either alone or together with measles, mu...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00312858
A study in two parts (Part A and Part B) to evaluate the responsiveness of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00886613
Treatments Being Tested
This investigator-initiated study will serve as a sub-study for the America...
Status
Completed
Location
St. Luke's Health System
Start Date
2014-05-08
Trial ID
NCT03604406
Treatments Being Tested
The purpose of this study is to determine whether the investigational zoste...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00231816
Treatments Being Tested
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391